Boehringer Ingelheim Canada is seeking an epidemiology-focused skilled to lead real-world evidence and phase IV research initiatives. This role supports asset reimbursement, health technology assessments, and value demonstration across our product portfolio.
Responsibilities include developing evidence generation strategies, monitoring reimbursement trends, and guiding cross-functional teams to ensure timely, high-quality outcomes. Flexible hybrid office-based in Burlington, ON.